https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51670 Wed 13 Sep 2023 10:07:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47072 Wed 13 Mar 2024 09:25:37 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49760 Tue 30 May 2023 18:39:10 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6919 1.0 mm) primary melanoma. It was 18 and 17.3 in subcutaneous and lymph node metastases, respectively (P < 0.0001). GRP78 expression was positively correlated with increasing tumour thickness (P = 0.001) and with increasing dermal tumour mitotic index (P = 0.0004). Disease-free survival (χ² = 8.0703, P = 0.0045) and overall survival (χ² = 6.2633, P = 0.0123) in melanoma patients with IRS >25 were significantly lower than in melanoma patients with IRS <25. Conclusions: GRP78 expression appears to correlate with known correlates of melanoma progression and survival and requires further evaluation as a prognostic biomarker in melanoma.]]> Sat 24 Mar 2018 08:34:50 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28082 Sat 24 Mar 2018 07:39:48 AEDT ]]>